Prof. Dr. Burçak YILMAZ

Tıbbi İlgi Alanları

• Radyonüklid Tedaviler
• PET-BT ve PET-MRI Görüntüleme &amp
• Raporlama
• Konvansiyonel Nükleer Tıp Görüntüleme &amp
• Raporlama (SPECT/BT, Gama Kamera)

Özgeçmiş

Eğitim

• Okul Birinciliği – Bahçeşehir Koleji (2000)
• Yüksek Lisans – Tıp Fakültesi (İstanbul Üniversitesi-Cerrahpaşa - İngilizce Tıp, 2006)
• Doktora – Nükleer Tıp (İstanbul Üniversitesi-Cerrahpaşa, 2012)
• Doktora – Moleküler Onkoloji (Sağlık Bilimleri Üniversitesi, 2018 - Halen)

Deneyim

• Tıpta Uzmanlık Öğrencisi – İstanbul Üniversitesi-Cerrahpaşa, Nükleer Tıp ABD (2007-2012)
• Uzman Doktor - Nükleer Tıp – Sağlık Bilimleri Üniversitesi’ne bağlı EAH’leri (İstanbul) (2012-2020)
• Observer Doctor – University of Washington, Nuclear Medicine Department, Seattle, USA (2017)
• Doçent Doktor - Nükleer Tıp – Sağlık Bilimleri Üniversitesi - İstanbul EAH (Mart 2020)
• Doçent Doktor - Nükleer Tıp (Eğitim ve İdari Sorumlusu) – Sağlık Bilimleri Üniversitesi - Başakşehir Çam ve Sakura Şehir Hastanesi, Nükleer Tıp Kliniği (2020-2022)
• Doçent Doktor - Nükleer Tıp – Medipol Üniversitesi Bahçelievler Hastanesi (2022-2023)
• Postdoctoral Scholar – Oregon Health and Science University, Nuclear Medicine Department, Portland, USA (2023-2024)
• Doçent Doktor - Nükleer Tıp – Biruni Üniversitesi Tıp Fakültesi Hastanesi (2025 - Halen)

Diller

• İngilizce
• Almanca

Ücret Bilgisi

Muayene ücretlerini öğrenmek için arayın.

Ödeme Yöntemleri

• Nakit
• Kredi Kartı
• Havale / EFT

Adresler

Tarif Al

Bilimsel Yayınlar

Bilimsel Üyelikler

• Türkiye Nükleer Tıp Derneği

Yayınlar

• A1. Yılmaz B, Şahin S, Ergül N, Çolakoğlu Y, Baytekin HF, Sökmen D, Tuğcu V, Taşçı Aİ, Çermik TF. 99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients. Ann Nucl Med. 2022 Apr 15. doi: 10.1007/s12149- 022-01741-9.
• A2. Çermik TF, Ergül N, Yılmaz B, Mercanoğlu G. Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types. Clin Nucl Med. 2022 Apr 1;47(4):e333-e339. doi: 10.1097/RLU.0000000000004073.
• A3. Ergül N, Yılmaz B, Cin M, Çermik TF. 68Ga-DOTA-FAPI-04 PET/CT in Neuroendocrine Carcinoma of the Liver With Elevated AFP Level: Comparison With 18F-FDG PET/CT. Clin Nucl Med. 2022 Jan 1;47(1):e29-e31. doi: 10.1097/RLU.0000000000003811. PMID: 34284483.
• A4. Aksu A, Vural Topuz Ö, Yilmaz B, Karahan Şen NP, Acar E, Çapa Kaya G. Prediction of early biochemical response after 177Lu-PSMA radioligand therapy with 68Ga-PSMA PET, a different perspective with quantitative parameters. Nucl Med Commun. 2022 Apr 1;43(4):468-474. doi: 10.1097/MNM.0000000000001539. PMID: 35045552.
• A5. Aksu A, Vural Topuz Ö, Yılmaz G, Çapa Kaya G, Yılmaz B. Dual time point imaging of staging PSMA PET/CT quantification; spread and radiomic analyses. Ann Nucl Med. 2022 Mar;36(3):310-318. doi: 10.1007/s12149-021-01705-5. Epub 2022 Jan 6.
• A6. Aksu A, Bozkurt K, Yilmaz B. Tracheitis Diagnosed With 68Ga-PSMA PET/CT in a Patient With COVID-19. Clin Nucl Med. 2022 May 27. doi: 10.1097/RLU.0000000000004288.
• A7. Aksu A, Şin C, Yilmaz B. Adult Tiger Man: A Case of Dermatomyositis Associated With Thymoma. Clin Nucl Med. 2022 Jun 1;47(6):e448-e449. doi: 10.1097/RLU.0000000000004154. Epub 2022 Mar 30.
• A8. Yilmaz B, Nisli S, Ergul N,Gürsu Riza Umar,Açikgöz Özgür,Çermik Tevfik Fikret (2019). Effect of external cooling on Lu-177 PSMA uptake for parotid glands. Journal of Nuclear Medicine, 60(10), 1388- 1393. Doi: 10.2967/jnumed.119.226449
• A9. Yilmaz B, Dag Z, Ergul N, Çermik TF(2019). The ability of pretreatment F-18 FDG PET/CT metabolic parameters for predicting axillary lymph node and distant metastasis and overall survival. Nuclear Medicine Communications, 40(11), 1112-1121. Doi: 10.1097/MNM.0000000000001085
• A10. Yilmaz B, Turkay R, Colakoglu Y,Baytekin HF,Ergül N, Sahin S,Tugcu V,İnci E,Taşçi AI,Çermik TF (2019). Comparison of preoperative locoregional Ga-68 PSMA-11 PET/CT and mp-MRI results with postoperative histopathology of prostate cancer. The Prostate, 79(9), 1007-1017. Doi: 10.1002/pros.23812
• A11. Yilmaz B,Dağ Z,Ergül N,Çermik TF (2019). The efficacy of pretreatment and after treatment 18FFDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer. Nuclear Medicine Communications, 40(3), 219-227, Doi: 10.1097/MNM.0000000000000969
• A12. Akaike G,Itani M,Shah HAJ, Yilmaz Gunes B,Assaker R,Behnia F(2018). PET/CT in the Diagnosis and Workup of Sarcoidosis: Focus on Atypical Manifestations. RadioGraphics, 38(5), 1536- 1549. Doi: 10.1148/rg.2018180053
• A13. Ergül N,Yilmaz Güneş B,Yücetaş U,Toktaş MG,Çermik TF(2018). 68Ga-PSMA-11 PET/CT in Newly Diagnosed Prostate Adenocarcinoma. Clinical Nuclear Medicine, 43(12), 422-427, Doi: 10.1097/RLU.0000000000002289
• A14. Dağ Z, Yilmaz B,Kutluhan DA, Unluer AD,Özkurt H,Kizilkaya HO,Arslan D (2019). Comparison of the prognostic value of F-18 FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy. Brachytherapy, 18(2), 154- 162. Doi: 10.1016/j.brachy.2018.11.005
• A15. Sağer MS,Hatipoğlu E,Güneş B,Asa S,Uslu L,Sönmezoğlu K (2018). Comparison of day 3 and day 5 thyroglobulin results after thyrogen injection in differentiated thyroid cancer patients. Therapeutic Advances in Endocrinology and Metabolism, 9(6), 177-183. Doi: 10.1177/2042018818770108
• A16. Yilmaz Güneş B,Önsel Ç,Sönmezoğlu K,Özaras R,Halac M,Tabak OF,Sağer MS,Mete B,Sayman B,Kanmaz B (2016). Diagnostic value of F-18 FDG PET/CT in patients with spondylodiscitis: Is dual time point imaging time worthy?. Diagnostic Microbiology and Infectious Disease, 85(3), 381-385, Doi: 10.1016/j.diagmicrobio.2016.03.021
• A17. Yilmaz B,Arslan H ,Gündoğan C,Güneş MN,Çermik TF (2019). False-Positive 68Ga-DOTATATE PET/CT in Active Chronic Prostatitis. Clinical Nuclear Medicine, 44(8), 499-500. Doi: 10.1097/RLU.0000000000002594
• A18. Gündoğan C,Yardimci AH,Yilmaz Güneş B,Çermik TF (2019). Subacute Venous Infarct Mimicking Cerebral Metastasis in 18F-FDG PET/CT. Clinical Nuclear Medicine, 44(2), 120-122, Doi: 10.1097/RLU.0000000000002391 ARTICLES AND RESEARCHES Articles published in international and national peer-reviewed journals
• A19. Bulut Nilüfer,Yilmaz Burçak (2018). Misleading 18FDG-PET/CT finding caused by chronic HIV infection in a patient with gastric carcinoma: a case report. International Journal of STD AIDS, 29(1), 96- 98, Doi: 10.1177/0956462417724709,
• A20. Itani Malak,Yilmaz Güneş Burçak,Akaike Gensuke,Behnia Fatemeh (2017). Lacrimal gland uptake on F-18 florbetapir amyloid positron emission tomography scan. Radiology Case Reports, 13(1), 265-268, Doi: 10.1016/j.radcr.2017.10.029
• A21. Bulut Nilüfer,Dağistanli Sevinç,Yilmaz Burçak,Atay Faruk O (2017). Surgical Approach to Anorectal Melanoma with PET-CT Staging: A Case Report. The Surgery Journal, 3(04), 177- 180, Doi: 10.1055/ s-0037-1608902
• A22. Yilmaz Güneş Burçak,Özvar Fatih Hikmet,Demirci Emre,Özkurt Hüseyin,Baytekin Halil Firat,Kabuli Hamit (2017). Parasitic Infestation Mimicking Hepatic Metastasis with Four Different Imaging Modalities in a Patient with Breast Carcinoma. The Breast Journal, 23(4), 468- 470, Doi: 10.1111/tbj.12771
• A23. Yilmaz Güneş Burçak,Akbayir Özgür,Demirci Emre,Ozaydin İpek (2016). Clinical, pathological and (18)F-FDG PET/CT findings in synchronous primary vaginal and endometrial cancers. Hellenic journal of nuclear medicine, 19(2), 170-2, Doi: 10.1967/s002449910374
• A24. Arslantaş E, Ayçiçek A, Akıcı F, Özkara S, Yılmaz B, Özdemir N, Bayram C. Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin's lymphoma. Nuklearmedizin. 2023 Feb;62(1):20-26. English. doi: 10.1055/a-1972-9292.
• A24. Yilmaz Güneş Burçak,Özvar Fatih Hikmet (2017). Radiation Induced Secondary LungCancer Detected with F-18 FDG-PET/CT 20 Years after Radiotherapy of BreastCancer. SM Journalof BiomedicalEngineering, 3(2), 1017-8
• A25. Vural Topuz Ö, Omak Ö, Yılmaz B. Primary Isolated Breast Lymphoma Presenting as Primary Breast Cancer with 18F-FDG PET/CT. Mol Imaging Radionucl Ther. 2023 Feb 23;32(1):83-86. doi: 10.4274/mirt.galenos.2022.58671.
• A26. Chalker C, Yilmaz B, Trone K, Parecki G, Chen A, Lim JY, Mallak N, Sokolova AO. Use of PSMA PET/CT to detect prostate cancer metastatic to a preexisting thyroid nodule. NPJ Precis Oncol. 2024 Jun 15;8(1):132. doi: 10.1038/s41698-024-00619-5.
• A27. Mallak N, Yilmaz B, Meyer C, Winters C, Mench A, Jha AK, Prasad V, Mittra E. Theranostics in Neuroendocrine Tumors: Updates and Emerging Technologies. Curr Probl Cancer. 2024 Oct;52:101129. doi: 10.1016/j.currproblcancer.2024.101129.
• Yerli hakemli dergilerde yayınlanmış makaleler
• B1. Yilmaz Güneş Burçak,Erez Özlem,Gündoğan Cihan,Ergül Nurhan (2019). The Evaluation of External Dose Rate Measurements of Patients During and After F-18 FDG PET/CT Imaging andAppropriate Discharge Time from PET/CT Department. Istanbul Medical Journal (İstanbul Tıp Dergisi), 20(3), 188-192., Doi: 10.4274/imj.galenos.2018.85698,
• B2. Yilmaz Burçak,Gündoğan Cihan (2019). The effect of transarterial Y-90 microsphere treatment of liver tumors on biochemical parameters. Istanbul Medical Journal (İstanbul Tıp Dergisi), 20(5), 436-440., Doi: 10.4274/imj.galenos.2019.24444
• B3. Dağ S, Doğan Ak, E Canaz, Arslan Nd, Yilmaz B. Diagnostic Accuracy of Preoperative Metabolic 18F-FDG PET/CT Parameters for Patients with Endometrial Cancer Treated with Postoperative Radiation Therapy. Cam and Sakura Med J 2021;1(1):14-23. DOI: 10.4274/csmedj.galenos.2021.2021- 8-9.
• B4. Arslan Nd, Dağ S, Doğan Ak,Gurcay N, Ozkurt H, Yilmaz B. Regression of Hypermetabolic Splenic Granulomata Mimicking Metastases Following Non-targeted Effect of Radiotherapy for Uterine Cervical Carcinoma. Cam and Sakura Med J 2021;1(1):37-42. DOI: 10.4274/csmedj.galenos.2021.2021-8-6
• B5.Gündoğan C, Ergül N, Serin H, Beyhan E, Yılmaz B, Çermik TF. Prognostic Role of Interleukin-23 in Prostate Adenocarcinoma: Comparison with Gallium-68 Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Computed Tomography Findings. IMJ 2021;22:320-325
• B6. Akgün E, Gür F, Yılmaz B. Diffuse Bone Marrow Involvement of Langerhans Cell Histiocytosis Detected with F-18 FDG PET/CT. Cam and Sakura Med J. 2022 Aug;2(2):80-81. doi:10.4274/ csmedj.galenos.2022.2022-4-1.